Moderna
MRNA
#1167
Rank
ยฃ12.66 B
Marketcap
ยฃ32.91
Share price
-0.45%
Change (1 day)
-51.45%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2023 (TTM): -ยฃ7.37

According to Moderna 's latest financial reports the company's current EPS (TTM) is -ยฃ7.22. In 2022 the company made an earnings per share (EPS) of ยฃ16.69 a decrease over its 2021 EPS that were of ยฃ23.93.

EPS history for Moderna from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ7.37-144.17%
2022ยฃ16.69-30.25%
2021ยฃ23.93-1660.82%
2020-ยฃ1.5325.16%
2019-ยฃ1.2337.04%
2018-ยฃ0.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-ยฃ1.34-81.51%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.44-119.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ2.39-66.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ3.25-55.03%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.96-140.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-ยฃ1.34-81.40%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ11.13-254.11%๐Ÿ‡บ๐Ÿ‡ธ USA